Liz Highleyman

Tenofovir was associated with a lower risk of hepatocellular carcinoma, but this might be related to other factors as well.

Study finds that having more diverse gut bacteria was associated with better response to immunotherapy.

Balversa led to tumor regression in about a third of patients with susceptible genetic mutations.

Bintrafusp shrank tumors in over a third of patients with cervical, anal or head and neck cancer.

Umbralisib may offer a chemotherapy-free option for people with relapsed or nonresponsive marginal zone lymphoma.

Ibrance appears safe and effective for men in real-world use.

The VA has cured HCV in nearly 100,000 veterans, which will dramatically reduce the development of advanced liver disease and liver cancer.

Researchers continue to develop new drugs that target cancer with specific genetic mutations anywhere in the body.

Two types of immunotherapy plus chemotherapy shrank tumors in most patients in an early study.

Use of cost-reducing strategies is still common, but has decreased since 2013.

The “king of the surf guitar” said he had to continue touring throughout his seventies to afford medical expenses.

Digital breast tomosynthesis allowed many women to avoid diagnostic biopsies without compromising cancer detection.

Ned Sharpless has been appointed interim head of the regulatory agency after the unexpected resignation of the commissioner.

Kadcyla reduces the risk of breast cancer recurring and spreading after surgery.

Women who had breast-conserving surgery rather than mastectomy report better quality of life.